They found that shRNA acting against PCSK9 significantly inhibited the phosphorylation of p38 and JNK [49], indicating that PCSK9 promoted the development and progression of atherosclerosis by mediating the apoptosis of endothelial cells via the p38/JNK/MAPK signaling pathway. The gene discussed is PCSK9; the disease is atherosclerosis.